Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. Issue 3 (21st September 2021)
- Record Type:
- Journal Article
- Title:
- Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. Issue 3 (21st September 2021)
- Main Title:
- Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma
- Authors:
- Petros, Firas G.
Choi, Woonyoung
Qi, Yuan
Moss, Tyler
Li, Roger
Su, Xiaoping
Guo, Charles C.
Czerniak, Bogdan
Dinney, Colin
McConkey, David J.
Matin, Surena F. - Abstract:
- Abstract : Purpose: We compared upper tract urothelial carcinoma (UTUC) and bladder urothelial carcinoma (BUC) in same-patient metachronous UTUC and synchronous UTUC and BUC using next-generation sequencing. Materials and Methods: Consecutive untreated same-patient samples of UTUC and BUC were macrodissected from unstained formalin-fixed, paraffin-embedded slides after quality control. Samples were divided into 4 groups: 1) UTUC-metachronous BUC, 2) BUC-metachronous UTUC, 3) synchronous UTUC-BUC, 4) UTUC without BUC. Exclusions were inadequate clinical data or histological tumor purity <30%. Whole transcriptome RNA sequencing was performed. After quality assessment, gene expression clusters using unsupervised hierarchical consensus clustering and correlation with pertinent clinicopathologic variables, a prior RNASeq data set and other published data were performed. Results: RNAseq was performed on 95 samples (UTUC=61, BUC=34) from 40 untreated patients. Unsupervised consensus clustering segregated the tumors into 2 clusters that were enriched with BASE47 basal-like or luminal-like gene expression. Almost two-thirds (61.9%) of Group 2 tumors were basal-like, while the majority of Groups 1, 3, 4 (80.6%, 70.0% and 69.6%, respectively) were luminal-like (p=0.017). Further analyses revealed that the differences in basal-like and luminal-like gene expression were associated with differential fibroblast and immune cell gene expression signatures. In all, 87.5% of metachronousAbstract : Purpose: We compared upper tract urothelial carcinoma (UTUC) and bladder urothelial carcinoma (BUC) in same-patient metachronous UTUC and synchronous UTUC and BUC using next-generation sequencing. Materials and Methods: Consecutive untreated same-patient samples of UTUC and BUC were macrodissected from unstained formalin-fixed, paraffin-embedded slides after quality control. Samples were divided into 4 groups: 1) UTUC-metachronous BUC, 2) BUC-metachronous UTUC, 3) synchronous UTUC-BUC, 4) UTUC without BUC. Exclusions were inadequate clinical data or histological tumor purity <30%. Whole transcriptome RNA sequencing was performed. After quality assessment, gene expression clusters using unsupervised hierarchical consensus clustering and correlation with pertinent clinicopathologic variables, a prior RNASeq data set and other published data were performed. Results: RNAseq was performed on 95 samples (UTUC=61, BUC=34) from 40 untreated patients. Unsupervised consensus clustering segregated the tumors into 2 clusters that were enriched with BASE47 basal-like or luminal-like gene expression. Almost two-thirds (61.9%) of Group 2 tumors were basal-like, while the majority of Groups 1, 3, 4 (80.6%, 70.0% and 69.6%, respectively) were luminal-like (p=0.017). Further analyses revealed that the differences in basal-like and luminal-like gene expression were associated with differential fibroblast and immune cell gene expression signatures. In all, 87.5% of metachronous tumors maintained subtype membership. Conclusions: Gene expression analysis of same-patient metachronous UTUC-BUC suggests that the majority of mUTUC developing after BUC appear more basal-like, while synchronous and initial UTUC tumors appear luminal-like. Metachronous tumors largely maintain molecular subtype membership of the initial tumor regardless of chronologic development or anatomical origin. … (more)
- Is Part Of:
- Journal of urology. Volume 206:Issue 3(2021)
- Journal:
- Journal of urology
- Issue:
- Volume 206:Issue 3(2021)
- Issue Display:
- Volume 206, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 206
- Issue:
- 3
- Issue Sort Value:
- 2021-0206-0003-0000
- Page Start:
- 548
- Page End:
- 557
- Publication Date:
- 2021-09-21
- Subjects:
- RNA -- urinary bladder neoplasms -- ureteral neoplasms -- genome
Genitourinary organs -- Periodicals
Urology -- Periodicals
Urology -- Periodicals
Urologie -- Périodiques
Urologie
616.6 - Journal URLs:
- http://catalog.hathitrust.org/api/volumes/oclc/1754854.html ↗
http://www.jurology.com ↗
http://www.sciencedirect.com/science/journal/00225347 ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/JU.0000000000001788 ↗
- Languages:
- English
- ISSNs:
- 0022-5347
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5071.900000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24128.xml